DaVita Inc.
DVAHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframeHeadquartered within the healthcare sector, DaVita Inc. focuses on Medical Care Facilities services and products. DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. With a market capitalization of $12.06B, it sits in large-cap territory. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.
Market Cap
$12.06B
Beta
0.84
P/E (TTM)
18.12
P/E (Fwd)
10.94
EPS (TTM)
$10.37
EPS (Fwd)
$17.18
ROE
81.0%
ROA
7.5%
Cash
$666.5M
Total Debt
$13.22B
Free CF
$999.7M
52W Change
37.4%
Annual Financials
Cash vs Debt
The company holds $666.5M in cash, though total debt stands at $13.22B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $999.7M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 81.0% points to exceptionally high capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 7.5% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $11.61B to $13.64B.
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing DVA.